Orchid Pharma (LUX:ORCHP) 9-Day RSI: N/A (As of Jul. 11, 2026)


LUX:ORCHP Orchid Pharma Ltd LUX:ORCHP
60 GF Score
Price $5.45
GF Value $4.68
! 10 Warning Signs
View Full Analysis

What is Orchid Pharma 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-11), Orchid Pharma's 9-Day RSI is N/A.

The industry rank for Orchid Pharma's 9-Day RSI or its related term are showing as below:

LUX:ORCHP's 9-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.15
* Ranked among companies with meaningful 9-Day RSI only.

Orchid Pharma  (LUX:ORCHP) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

Orchid Pharma 9-Day RSI Related Terms

LUX:ORCHP vs ZTS, UTHR: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Pharma's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orchid Pharma 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orchid Pharma's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Orchid Pharma's 9-Day RSI falls into.


LUX:ORCHP
60GF Score
Orchid Pharma Ltd LUX:ORCHP
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orchid Pharma  (LUX:ORCHP) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Orchid Pharma (LUX:ORCHP) Overvalued in 2026?

Based on GuruFocus' analysis, Orchid Pharma stock appears to be overvalued. The current stock price of $5.45 is trading 16.5% above its estimated GF Value™ of $4.68.

Key valuation signals for LUX:ORCHP:

  • 9-Day RSI: N/A
  • GF Value™: $4.68 vs. price of $5.45 (16.5% above fair value)
  • GF Score™: 60/100 with 10 warning signs

No single metric tells the full story. See the LUX:ORCHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orchid Pharma Business Description

Address Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.
60GF Score

Get the complete analysis for LUX:ORCHP

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$4.68
GF Value